Novel Targeted Liposomal Treatment for Tuberculosis
- 技術優勢
- Targeted deliverySustained releaseDecreased side effects
- 技術應用
- mycobacterium infection treatment
- 詳細技術說明
- Our inventorΓÇÖs have developed novel anti-TB liposomes that are capable of encapsulating common clinical anti-TB drugs and can be coated with TGF-╬▓1 siRNA. These multifunctional liposomes have proven to be stable under ambient conditions, display low cytotoxicity, and prolonged release in in vitro studies. This nanoparticle system address many of the issues with the current gold standard ofchemotherapeutic treatment and has the potential to significantly improve the treatment of tuberculosis.
- *Abstract
-
Researchers at the University of South Florida have developed novel targetedPEGylated liposomes for co-delivery of siRNA and anti-tubercular drugs for the treatment of mycobacterium infection.
- 國家/地區
- 美國
欲了解更多信息，請點擊 這裡
